日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

PARP inhibition with olaparib and talazoparib for HER2-negative advanced breast cancer-Results from the prospective PRAEGNANT registry

使用奥拉帕尼和他拉唑帕尼抑制PARP活性治疗HER2阴性晚期乳腺癌——来自前瞻性PRAEGNANT注册研究的结果

Hörner, Manuel; Hartkopf, Andreas; John, Nelson; Ziegler, Philipp; Häberle, Lothar; Uhrig, Sabrina; Goossens, Chloë; Amann, Niklas; Cieslik, Jan-Philipp; Tretschock, Lara M; Dannehl, Dominik; Deutsch, Thomas M; Dimpfl, Moritz; Ehlert, Max; Eichstädt, Kathleen; Englisch, Alexander; Köpke, Melitta B; Krückel, Annika; Link, Theresa; Müller, Annika; Reinhardt, Kristin; Roth, Jonas; Schäffler, Henning; Sych, Lea; Tauber, Nikolas; Tegeler, Christian M; Wichmann, Catharina; Banys-Paluchowski, Maggie; Princk, Henriette; Rody, Achim; Brucker, Sara Y; Ditsch, Nina; Ettl, Johannes; Fehm, Tanja; Hack, Carolin C; Hadji, Peyman; Hein, Alexander; Janni, Wolfgang W; Kolberg, Hans-Christian; Lüftner, Diana; Lux, Michael P; Müller, Volkmar; Taran, Florin-Andrei; Tesch, Hans; Wallwiener, Diethelm; Marmé, Frederik; Seitz, Stephan; Belleville, Erik; Michel, Laura L; Wallwiener, Markus; Fasching, Peter A; Schneeweiss, Andreas; Maurer, Christian

Alpelisib and Fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the German PRAEGNANT trial

在德国PRAEGNANT试验中,Alpelisib和Fulvestrant被用于治疗PIK3CA突变、激素受体阳性、HER2阴性的晚期乳腺癌。

Hörner, Manuel; Tretschock, Lara M; John, Nelson; Ziegler, Philipp; Häberle, Lothar; Uhrig, Sabrina; Goossens, Chloë; Amann, Niklas; Cieslik, Jan-Philipp; Dannehl, Dominik; Deutsch, Thomas M; Dimpfl, Moritz; Ehlert, Max; Eichstädt, Kathleen; Englisch, Alexander; Köpke, Melitta B; Krückel, Annika; Link, Theresa; Müller, Annika; Reinhardt, Kristin; Roth, Jonas; Schäffler, Henning; Sych, Lea; Tegeler, Christian M; Wichmann, Catharina; Banys-Paluchowski, Maggie; Princk, Henriette; Rody, Achim; Brucker, Sara Y; Ditsch, Nina; Ettl, Johannes; Fehm, Tanja; Hack, Carolin C; Hadji, Peyman; Hein, Alexander; Janni, Wolfgang W; Kolberg, Hans-Christian; Lüftner, Diana; Lux, Michael P; Müller, Volkmar; Schneeweiss, Andreas; Taran, Florin-Andrei; Tesch, Hans; Wallwiener, Diethelm; Marmé, Frederik; Seitz, Stephan; Belleville, Erik; Hartkopf, Andreas; Michel, Laura L; Wallwiener, Markus; Fasching, Peter A; Tauber, Nikolas

Prospective controlled study comparing patient-reported outcomes after daily online adaptive radiotherapy or conventional IGRT in patients with prostate cancer

一项前瞻性对照研究,比较前列腺癌患者接受每日在线自适应放射治疗或常规图像引导放射治疗后的患者报告结局。

Kalinauskaite, Goda; Künzel, Luise A; Rubarth, Kerstin; Nguyen, Thao; Dannehl, Jakob; Höhne, Celina; Beck, Marcus; Bauer, Julia; Zips, Daniel; Senger, Carolin

The adverse prognostic impact of reduced chemotherapy dose intensity appears attenuated in early breast cancer patients with treatment-relevant neutropenia: a retrospective cohort study

一项回顾性队列研究表明,降低化疗剂量强度对早期乳腺癌伴治疗相关性中性粒细胞减少症患者的不良预后影响似乎有所减弱。

Eissler, K; Engler, T; Dannehl, D; Schönfisch, B; Englisch, J; Hartkopf, A D; Brucker, S Y; Grischke, E M; Volmer, L L; Englisch, Alexander

Impact of chemotherapy dose capping on treatment intensity and survival in early breast cancer patients with high body surface area

化疗剂量上限对体表面积较大的早期乳腺癌患者的治疗强度和生存率的影响

Englisch, A; Eissler, K; Dannehl, D; Englisch, J; Hartkopf, A D; Brucker, S Y; Grischke, E M; Volmer, L L; Engler, T

High Adherence to Adjuvant Endocrine Therapy Improves Outcome in Early Breast Cancer - Results from a Large Real-World Claims Data Analysis in Germany

德国一项大型真实世界索赔数据分析表明,早期乳腺癌患者对辅助内分泌治疗的高依从性可改善预后。

Dannehl, Dominik; Dijkstra, Tjeerd; Volmer, Lea; Hahn, Markus; von Au, Alexandra; Hawighorst-Knapstein, Sabine; Chaudhuri, Ariane; Wallwiener, Markus; Bauer, Armin; Wallwiener, Diethelm; Brucker, Sara; Wallwiener, Stephanie; Engler, Tobias; Hartkopf, Andreas

Time Toxicity of Endocrine-based Oral CDK4/6 Inhibitor Therapies

内分泌靶向口服 CDK4/6 抑制剂疗法的时间毒性

Schäffler, Henning; Heublein, Sabine; Lichtblau, Julia; Wisniewski, Lisa; Rack, Brigitte; Janni, Wolfgang; Englisch, Alexander; Englisch, Johannes; Engler, Tobias; Hartkopf, Andreas; Brucker, Sara; Hilmer, Lisbeth; Fick, Franziska; Kohls, Fabian; Banys-Paluchowski, Maggie; Rody, Achim; Dannehl, Dominik; Tauber, Nikolas

Choriocarcinoma: Navigating risk, resistance, and remarkable curability

绒毛膜癌:风险、耐药性和卓越的治愈率

Dannehl, Dominik; Taran, Florin-Andrei

Prediction of secondary metabolites in hydroponically produced tomatoes: multivariate influence of abiotic climatic factors as well as photosynthesis and transpiration rates.

水培番茄次生代谢产物的预测:非生物气候因素以及光合作用和蒸腾速率的多变量影响

Devadze Grigorij, Dannehl Dennis, Nerlich Annika, Schmidt Uwe, Streif Stefan

Oral Maintenance Therapy in Early Breast Cancer-How Many Patients Are Potential Candidates?

早期乳腺癌口服维持治疗——有多少患者符合条件?

Tauber, Nikolas; Hilmer, Lisbeth; Dannehl, Dominik; Fick, Franziska; Hemptenmacher, Franziska; Krawczyk, Natalia; Meyer-Lehnert, Thomas; Milewski, Kay; Princk, Henriette; Hartkopf, Andreas; Rody, Achim; Banys-Paluchowski, Maggie